Posttransplant lymphoproliferative disease: a case report and review for the general pediatrician

Christine R Kincaid1, Linda S Nield, Renee S Moore

  • 1West Virginia University School of Medicine, Morgantown, West Virginia 26506, USA.

Insights

Pediatricians should consider posttransplant lymphoproliferative disease (PTLD) in children with immunosuppression. Early recognition is crucial for timely diagnosis and management of this rare condition.

Area of Science:

  • Pediatric Oncology
  • Immunology
  • Transplant Medicine

Background:

  • Posttransplant lymphoproliferative disease (PTLD) is a serious complication following organ or stem cell transplantation.
  • It arises from the proliferation of lymphocytes, often associated with Epstein-Barr virus (EBV) infection in the context of immunosuppression.

Observation:

  • A case report details a 19-year-old male initially diagnosed with peritonsillar abscess who later developed PTLD.
  • This highlights the diverse and sometimes non-specific initial presentations of PTLD in pediatric patients.

Findings:

  • PTLD can mimic common childhood infections or inflammatory conditions, delaying definitive diagnosis.
  • Familiarity with PTLD's varied clinical spectrum is essential for pediatricians managing immunosuppressed children.

Implications:

  • Increased vigilance and consideration of PTLD are necessary in ill children on long-term immunosuppressive therapy.
  • Prompt evaluation and diagnosis of PTLD can improve patient outcomes and prognosis.
  • This case underscores the importance of a broad differential diagnosis in pediatric transplant recipients.